Dr. Hayder Dhafir Hashim, MD

Dr. Hashim practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.

Dr. Hashim's NPI, 1104069442, was assigned on April 16, 2009. Dr. Hashim holds Maryland license D0081932.

Dr. Hashim's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.

Dr. Hashim's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Hashim is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Hashim to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hashim practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Hashim's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Hashim is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Hashim is licensed in Maryland.

CMS data shows 834 Medicare services from Dr. Hashim across 12 procedure codes in 2024, for 447 Medicare patients. Medicare paid $149,788 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 447 Medicare patients who saw Dr. Hashim in 2024. The largest group is 65 to 74, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hashim's median patient age at 67, with 34% women.

In 2024, Dr. Hashim wrote 157 Medicare Part D claims for 67 patients. 97% of them were for generic drugs. CMS names the drug for 117 of them, across 1 drug with 11 or more claims each, at $725 in total drug cost. In 2023, CMS named 108 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Hashim for performance year 2024, reported as part of a group. Dr. Hashim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 81 procedures of coronary angioplasty and stenting by Dr. Hashim, more than 94% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 99 papers to Dr. Hashim, published from 2015 to 2025. 2024 was the busiest year, with 24. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Coronary Angiography. Dr. Hashim has published most often in Cardiovasc Revasc Med. Dr. Hashim's most frequent co-authors are Ron Waksman, MD, Brian Christopher Case, MD and Lowell Franklin Satler, MD.

Dmand AI links Dr. Hashim to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Inferior Wall Myocardial Infarction and Anterior Wall Myocardial Infarction.

CMS Open Payments shows 1,438 general payments to Dr. Hashim from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Abbott Laboratories paid the most, $331,881.